BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27869413)

  • 21. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.
    Paulke-Korinek M; Fischmeister G; Grac A; Rendi-Wagner P; Kundi M; Mohsenzadeh-Rabbani A; Moritz K; Fenninger B; Jarisch R; Jasinska J; Holzmann H; Wiedermann U; Kollaritsch H
    Vaccine; 2011 Jul; 29(32):5130-6. PubMed ID: 21624412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re-immunisation schedule in leukaemic children after intensive chemotherapy: a possible strategy.
    Fioredda F; Plebani A; Hanau G; Haupt R; Giacchino M; Barisone E; Balbo L; Castagnola E
    Eur J Haematol; 2005 Jan; 74(1):20-3. PubMed ID: 15613102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study.
    Heijstek MW; van Gageldonk PG; Berbers GA; Wulffraat NM
    Ann Rheum Dis; 2012 Jun; 71(6):948-54. PubMed ID: 22172491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunodeficiency in children with acute lymphoblastic leukemia after completion of modern aggressive chemotherapeutic regimens.
    Brodtman DH; Rosenthal DW; Redner A; Lanzkowsky P; Bonagura VR
    J Pediatr; 2005 May; 146(5):654-61. PubMed ID: 15870670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Revaccination of children after completion of standard chemotherapy for acute lymphoblastic leukaemia: a pilot study comparing different schedules.
    Lehrnbecher T; Schubert R; Allwinn R; Dogan K; Koehl U; Grüttner HP
    Br J Haematol; 2011 Mar; 152(6):754-7. PubMed ID: 21250973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid].
    Gil Miguel A; Astasio Arbiza P; Ortega Molina P; Domínguez Rojas V; González López A
    An Esp Pediatr; 1999 May; 50(5):459-62. PubMed ID: 10394183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunodeficiency in long-term survivors of acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster therapy.
    Smith S; Schiffman G; Karayalcin G; Bonagura V
    J Pediatr; 1995 Jul; 127(1):68-75. PubMed ID: 7608814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the immune status against measles, mumps, and rubella in adult allogeneic hematopoietic stem cell transplantation recipients.
    Kawamura K; Yamazaki R; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Terasako-Saito K; Kimura S; Kikuchi M; Nakasone H; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y
    Hematology; 2015 Mar; 20(2):77-82. PubMed ID: 24992512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological Reconstitution in Children After Completing Conventional Chemotherapy of Acute Lymphoblastic Leukemia is Marked by Impaired B-cell Compartment.
    Koskenvuo M; Ekman I; Saha E; Salokannel E; Matomäki J; Ilonen J; Kainulainen L; Arola M; Lähteenmäki PM
    Pediatr Blood Cancer; 2016 Sep; 63(9):1653-6. PubMed ID: 27163649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Humoral and cellular immune responses to measles and tetanus: the importance of elapsed time since last exposure and the nature of the antigen.
    Viana PO; Ono E; Miyamoto M; Salomao R; Costa-Carvalho BT; Weckx LY; de Moraes-Pinto MI
    J Clin Immunol; 2010 Jul; 30(4):574-82. PubMed ID: 20405177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles-mumps-rubella revaccination; 18 months vs. 4-6 years of age: potential impacts of schedule changes.
    Saffar MJ; Fathpour GR; Parsaei MR; Ajami A; Khalilian AR; Shojaei J; Saffar H
    J Trop Pediatr; 2011 Oct; 57(5):347-51. PubMed ID: 21078605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy.
    Aurpibul L; Puthanakit T; Sirisanthana T; Sirisanthana V
    Clin Infect Dis; 2010 May; 50(10):1415-8. PubMed ID: 20377409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serosurvey of measles, mumps and rubella antibodies in Saudi children.
    Al-Mazrou YY; Khalil MK; Tischer A; Al-Jeffri MH; Al-Ghamdi YS; Bakhsh MM; Mishkas AA; Elgizouli SA
    Saudi Med J; 2005 Oct; 26(10):1551-4. PubMed ID: 16228054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R; Rahman MM; Hassan Z; Hassan MS
    Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Kinetics of vaccine antibodies to tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococci after allogenic and autologous bone marrow transplantation and booster immunization. 1: The kinetics of vaccine antibodies to tetanus toxoid after allogenic and autologous bone marrow transplantation].
    Prager J; Baumert A; Hermann J; Fuchs D; Zintl F
    Kinderarztl Prax; 1992 Jun; 60(4-5):124-30. PubMed ID: 1495263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humoral immune response after post-chemotherapy booster diphtheria-tetanus-pertussis vaccine in pediatric oncology patients.
    Cheng FW; Leung TF; Chan PK; Lee V; Shing MK; Chik KW; Yuen PM; Li CK
    Pediatr Blood Cancer; 2009 Feb; 52(2):248-53. PubMed ID: 18937325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune reconstitution during maintenance therapy in children with acute lymphoblastic leukemia, relation to co-existing infection.
    El-Chennawi FA; Al-Tonbary YA; Mossad YM; Ahmed MA
    Hematology; 2008 Aug; 13(4):203-9. PubMed ID: 18796245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The multiplex method of estimation of humoral immunity to vaccine regulated childhood infections].
    Ersh AV; Poltavchenko AG; Pyankov SA; Agaphonov AP; Krivenchuk NA; Butorin DV
    Vopr Virusol; 2015; 60(1):41-5. PubMed ID: 26021074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of serologic immunity against vaccine-preventable diseases in children after thoracic transplantation.
    Urschel S; Cremer S; Birnbaum J; Dallapozza R; Fuchs A; Jäger G; Schmitz C; Belohradsky BH; Netz H
    Transpl Int; 2010 Jun; 23(6):619-27. PubMed ID: 20028497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunity to Measles, Mumps, and Rubella in US Children With Perinatal HIV Infection or Perinatal HIV Exposure Without Infection.
    Siberry GK; Patel K; Bellini WJ; Karalius B; Purswani MU; Burchett SK; Meyer WA; Sowers SB; Ellis A; Van Dyke RB; ;
    Clin Infect Dis; 2015 Sep; 61(6):988-95. PubMed ID: 26060291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.